Key facts
- It has raised $13.8M; the latest was Later Stage VC ($13.8M) in Mar 2025.
- Notable investors include IDG Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Vansea Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Vansea Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vansea Medical
Developer of the injection pen designed for healthcare. The company's products mainly focus on self-medication injection system solution development and manufacturing, which can be applied in the fields of insulin, growth hormone, GLP-1 drugs, peptide drugs, adrenaline drugs, etc., providing customers with reliable and innovative products.
- Sector
- Healthcare
- HQ
- Changzhou, China
- Founded
- 2016
- Employees
- 300
- Website
- wanhai-medical.com/
- Ownership
- Privately Held (backing)
Vansea Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vansea Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vansea Medical in its N-PORT filings yet. We sweep new filings monthly.